Skip to content
10-Q

Quarterly Report

SANGUI BIOTECH INTERNATIONAL INC

0001551163-20-000007

← back to feed
Filed
Feb 13, 2020 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2020 · Feb 13, 2020 202.73M sh
Short Term Debt Q2 2020 · Dec 31, 2019 $538.36K
Short Term Debt Q2 2020 · Jun 30, 2019 $478.36K
Stockholders Equity Q2 2020 · Dec 31, 2019 −$2K
Stockholders Equity Q2 2020 · Jun 30, 2019 $49.2K
Current Liabilities Q2 2020 · Dec 31, 2019 $701.58K
Current Liabilities Q2 2020 · Jun 30, 2019 $670.96K
Current Assets Q2 2020 · Dec 31, 2019 $52.99K
Current Assets Q2 2020 · Jun 30, 2019 $78.97K
Total Assets Q2 2020 · Dec 31, 2019 $55.99K
Total Assets Q2 2020 · Jun 30, 2019 $78.97K
Cost Of Revenue Q2 2020 · Dec 31, 2019 $0
Cost Of Revenue Q2 2020 · Dec 31, 2019 $0
Cost Of Revenue Q2 2020 · Dec 31, 2018 $26
Cost Of Revenue Q2 2020 · Dec 31, 2018 $99
Operating Cash Flow Q2 2020 · Dec 31, 2018 −$145.2K
Cash And Equivalents Q2 2020 · Dec 31, 2018 $36.24K
Cash And Equivalents Q2 2020 · Jun 30, 2018 $20.94K
Sga Expense Q2 2020 · Dec 31, 2018 $43.61K
Sga Expense Q2 2020 · Dec 31, 2018 $90.4K
Rd Expense Q2 2020 · Dec 31, 2018 $7.31K
Rd Expense Q2 2020 · Dec 31, 2018 $15.29K
Net Income restated Q2 2020 · Dec 31, 2018 −$56.36K
Net Income restated Q2 2020 · Dec 31, 2018 −$146.32K
Operating Income Q2 2020 · Dec 31, 2018 −$60.14K
Operating Income Q2 2020 · Dec 31, 2018 −$153.64K
Gross Profit Q2 2020 · Dec 31, 2018 $44.07K
Gross Profit Q2 2020 · Dec 31, 2018 $55.27K
Revenue Q2 2020 · Dec 31, 2018 $44.1K
Revenue Q2 2020 · Dec 31, 2018 $55.37K